U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188071188071Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaCompletedNo Results AvailableBipolar DisorderDrug: quetiapine fumaratehttps://ClinicalTrials.gov/show/NCT00090311
188072188072Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)CompletedNo Results AvailableHypercholesterolemiaDrug: MK0653A, ezetimibe (+) simvastatin|Drug: Comparator: Rosuvastatinhttps://ClinicalTrials.gov/show/NCT00090298
188073188073An Investigational Study of Gardasilâ„¢ (qHPV, V501) Vaccine in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)Active, not recruitingHas ResultsCondylomata AcuminataBiological: (Gardasilâ„¢) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine|Biological: Comparator: placebo (unspecified)https://ClinicalTrials.gov/show/NCT00090285
188074188074A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)CompletedNo Results AvailableColorectal SurgeryDrug: MK0826, ertapenem sodium|Drug: Comparator: cefotetanhttps://ClinicalTrials.gov/show/NCT00090272
188075188075Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)CompletedHas ResultsHeart FailureDrug: Losartan 50 mg|Drug: Losartan 150 mghttps://ClinicalTrials.gov/show/NCT00090259
1880761880762 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)CompletedNo Results AvailablePostoperative Nausea and VomitingDrug: MK0869, aprepitant|Drug: Comparator: ondansetron IVhttps://ClinicalTrials.gov/show/NCT00090246
188077188077Rotavirus Efficacy and Safety Trial (REST)(V260-006)CompletedHas ResultsRotavirus InfectionsBiological: Rotateqâ„¢|Biological: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00090233
188078188078A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501) in Women (V501-019)CompletedHas ResultsHealthy|Papillomavirus InfectionBiological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine|Biological: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00090220
188079188079Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)CompletedNo Results AvailableNausea|VomitingDrug: MK0869, aprepitant / Duration of Treatment: 3 days|Drug: Comparator: ondansetron / Duration of Treatment: 4 dayshttps://ClinicalTrials.gov/show/NCT00090207
188080188080Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%TerminatedNo Results AvailableKidney Failure, ChronicBiological: Immune Globulin Intravenous (Human), 10%https://ClinicalTrials.gov/show/NCT00090194
188081188081Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)CompletedNo Results AvailableChronic Low Back PainDrug: MK0663, etoricoxib / Duration of Treatment: 4 weeks|Drug: Comparator: diclofenac / Duration of Treatment: 4 weekshttps://ClinicalTrials.gov/show/NCT00090181
188082188082Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)CompletedNo Results AvailableHypercholesterolemia|Atherosclerotic Disease|Coronary DiseaseDrug: MK0653A , ezetimibe (+) simvastatin|Drug: Comparator: atorvastatin|Drug: Duration of Treatment: 6 weekshttps://ClinicalTrials.gov/show/NCT00090168
1880831880832 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)CompletedNo Results AvailablePostoperative Nausea and VomitingDrug: MK0869, aprepitant|Drug: Comparator: ondansetron IVhttps://ClinicalTrials.gov/show/NCT00090155
188084188084Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)CompletedHas ResultsAsthma, Exercise-InducedDrug: Comparator: Montelukast|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00090142
188085188085Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque PsoriasisTerminatedNo Results AvailableArthritis, PsoriaticDrug: Onercept|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00090129
188086188086The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: Neramexanehttps://ClinicalTrials.gov/show/NCT00090116
188087188087Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination TreatmentCompletedHas ResultsProstatic HyperplasiaDrug: dutasteride 0.5mg once daily for 4 years|Drug: tamsulosin 0.4mg once daily for 4 yearshttps://ClinicalTrials.gov/show/NCT00090103
188088188088Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNo Results AvailableMantle Cell Lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDrug: Elsamitrucinhttps://ClinicalTrials.gov/show/NCT00090090
188089188089Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected AdultsCompletedNo Results AvailableHIV InfectionsDrug: GW695634https://ClinicalTrials.gov/show/NCT00090077
188090188090A Test of MDMA-Assisted Psychotherapy in People With Posttraumatic Stress DisorderCompletedNo Results AvailablePosttraumatic Stress DisorderDrug: 3,4-methylenedioxymethamphetamine (MDMA)|Drug: lactose (placebo|Behavioral: Psychotherapyhttps://ClinicalTrials.gov/show/NCT00090064
188091188091FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed PatientsCompletedHas ResultsChronic Lymphocytic LeukemiaDrug: Rituximab|Drug: Fludarabine Phosphate|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00090051
188092188092Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's LymphomaCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: rituximabhttps://ClinicalTrials.gov/show/NCT00090038
188093188093XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary TumorsTerminatedNo Results AvailableBiliary Tract CancerDrug: becatecarin|Drug: 5-Fluorouracil Plus Leucovorinhttps://ClinicalTrials.gov/show/NCT00090025
188094188094Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: Olanzapine|Drug: Quetiapinehttps://ClinicalTrials.gov/show/NCT00090012
188095188095Lapatinib In Chemotherapy-Naive Or Metastatic Breast CancerCompletedHas ResultsNeoplasms, BreastDrug: Lapatinibhttps://ClinicalTrials.gov/show/NCT00089999
188096188096GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In AdultsCompletedNo Results AvailableSepsisDrug: Intravenous GR270773- Phospholipid Emulsion|Other: Placebohttps://ClinicalTrials.gov/show/NCT00089986
188097188097Study Of Ispinesib In Subjects With Breast CancerCompletedNo Results AvailableBreast CancerDrug: Ispinesibhttps://ClinicalTrials.gov/show/NCT00089973
188098188098Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)CompletedNo Results AvailableGastrointestinal CancerDrug: AMG 706https://ClinicalTrials.gov/show/NCT00089960
188099188099A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant RejectionCompletedNo Results AvailableRenal Transplantation|Graft RejectionDrug: Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]https://ClinicalTrials.gov/show/NCT00089947
188100188100SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving MethotrexateCompletedNo Results AvailableArthritis, RheumatoidDrug: SCIO-469|Drug: SCIO-469|Drug: Placebo|Drug: SCIO-469https://ClinicalTrials.gov/show/NCT00089921

* Görseller ve İçerik tekif hakkına sahip olabilir